Table 3 Subsite distribution among cancer cases eligible for survival analysis, Estonia, 1995–2006
From: Sex differences in cancer survival in Estonia: a population-based study
No of cases (%) | |||||
|---|---|---|---|---|---|
Cancer site | Subsite | ICD-O-3 | Men | Women | p-value* |
Mouth, pharynx | All | C00–14 | 1395 (100) | 451 (100) | p < 0.001 |
Lip | C00 | 158 (11) | 77 (17) | ||
Tongue and oral cavity | C01–06 | 591 (42) | 203 (45) | ||
Salivary glands | C07–08 | 95 (7) | 96 (21) | ||
Pharynx | C09–13 | 529 (38) | 70 (16) | ||
Other ill-defined sites | C14 | 22 (2) | 5 (1) | ||
Stomach | All | C16 | 2897 (100) | 2412 (100) | p < 0.001 |
Cardia | C16.0 | 249 (9) | 136 (6) | ||
Non-cardia | C16.1–16.4 | 1553 (54) | 1308 (54) | ||
Other | C16.5–16.8 | 238 (8) | 223 (9) | ||
Unspecified | C16.9 | 857 (29) | 745 (31) | ||
Colon | All | C18 | 1974 (100) | 2712 (100) | p < 0.001 |
Right | C18.0–18.3 | 630 (32) | 1055 (39) | ||
Transverse | C18.4 | 181 (9) | 308 (11) | ||
Left | C18.5–18.7 | 1089 (55) | 1263 (47) | ||
Overlapping | C18.8 | 38 (2) | 29 (1) | ||
Unspecified | C18.9 | 36 (2) | 57 (2) | ||
Rectum | All | C19–21 | 1603 (100) | 1582 (100) | p < 0.001 |
Rectosigmoid junction | C19 | 234 (14) | 253 (16) | ||
Rectum | C20 | 1326 (83) | 1229 (78) | ||
Anus, anal canal | C21 | 43 (3) | 100 (6) | ||
Skin melanoma | All | C44 | 533 (100) | 972 (100) | p < 0.001 |
Head and neck | C44.0–44.4 | 74 (14) | 133 (14) | ||
Trunk | C44.5 | 280 (52) | 280 (29) | ||
Upper limbs | C44.6 | 54 (10) | 147 (15) | ||
Lower limbs | C44.7 | 78 (15) | 352 (36) | ||
Overlapping, unspecified | C44.8–44.9 | 47 (9) | 60 (6) | ||